Newsletter
Drug testing industry tries to block cannabis rescheduling (Newsletter: June 12, 2026)
KY gov slams GOP lawmaker over medical marijuana comments; PA senator blames gov for cannabis bill defeat; MA anti-marijuana petitioner fired
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going.
Join us at https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
A drug testing industry group and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to block the Trump administration from moving forward with marijuana rescheduling—claiming that cannabis is a “dangerous drug that destroys lives.”
Kentucky Gov. Andy Beshear (D) slammed a top Republican lawmaker for a “complete lack of humanity” after he said law enforcement should prosecute people who act in accordance with a recent executive order to expand medical cannabis access.
A Pennsylvania Republican senator whose marijuana and hemp regulatory bill was defeated in a floor vote is blaming Gov. Josh Shapiro (D) for whipping Democratic votes against it—though the governor’s office says he prefers “comprehensive cannabis regulation” including a “revenue-generating adult-use market.”
A Massachusetts campaign working to put a measure to roll back marijuana legalization on the November ballot has fired a signature gatherer over “wholly unacceptable” conduct after a video was posted of him seeming to argue that voters who support legal cannabis access should sign the petitions in order to advance or protect reform.
/ FEDERAL
The U.S. Embassy and Consulates in Mexico issued a warning to U.S. citizens traveling for the World Cup that “drug possession or importation of drugs, including medical marijuana, is illegal in Mexico.”
The House Financial Services Subcommittee on Oversight and Investigations heard testimony from a Congressional Research Service official about money laundering associated with illicit marijuana cultivation operations.
The Senate bill to require federal officials to study hospital emergency room costs due to marijuana use got one new cosponsor for a total of two.
/ STATES
Rhode Island Gov. Dan McKee (D) signed legislation to address residency requirements that have prevented marijuana business licensing from advancing amid litigation.
A Virginia delegate said lawmakers should not include provisions to legalize recreational marijuana sales in budget legislation this month.
A New York appeals court overturned a preliminary injunction blocking enforcement actions against unlicensed marijuana stores. Regulators separately touted other recent court rulings on cannabis licensing and enforcement issues.
Florida regulators are considering changes to medical cannabis advertising and marketing rules.
Illinois regulators revised cannabis forms for new accessibility standards.
Nevada Cannabis Advisory Commission subcommittees will meet on Tuesday and Thursday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ INTERNATIONAL
A Guyanese court dismissed a marijuana trafficking charge against a former lawmaker.
/ SCIENCE & HEALTH
A study found that a “CBD-ASD hydrogel represents a stable, multifunctional delivery platform that overcomes CBD solubility limitations and enhances therapeutic efficacy for inflammatory skin diseases.”
A study demonstrated a “stable and clinically meaningful long-lasting antidepressant effect of one or two 25 mg doses psilocybin with adjunct psychotherapy up to twelve months in” treatment-resistant depression.
/ ADVOCACY, OPINION & ANALYSIS
Americans for Safe Access published a guide for states related to the Trump administration’s federal marijuana rescheduling move.
/ BUSINESS
Aurora Cannabis Inc. reported quarterly net revenue of C$84.8 million and a net loss from continuing operations of C$27.6 million.
Verano Holdings Corp. completed a 1-for-5 reverse stock split.
Glass House Brands Inc. filed a prospectus supplement in connection with an at-the-market distribution program allowing it to sell up to $100 million worth of shares.
Innovative Industrial Properties, Inc. announced that its operating partnership, IIP Operating Partnership, LP intends to offer $250 million aggregate principal amount of exchangeable senior notes.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
